Opening book details…
About this Medicine article
Benefit-Risk Assessment for Sofosbuvir/Velpatasvir/Voxilaprevir Based on Patient Population and HCV genotype: FDA's Evaluation by Struble, Kimberly; Chan-Tack, Kirk; Qi, Karen; Naeger, Lisa K.; Birnkrant, Debra is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Struble, Kimberly; Chan-Tack, Kirk; Qi, Karen; Naeger, Lisa K.; Birnkrant, Debra
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Elsevier BV; Wiley; Research Square (ISSN 0270-9139)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Struble, Kimberly; Chan-Tack, Kirk; Qi, Karen; Naeger, Lisa K.; Birnkrant, Debra
Browse all works by Struble, Kimberly; Chan-Tack, Kirk; Qi, Karen; Naeger, Lisa K.; Birnkrant, Debra